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A high-molecular-mass complex containing valyl-tRNA synthetase has been purified to homogeneity from 
rabbit liver. The molecular mass of the complex is about 800 kDa. The complex consists of four polypeptides 
of 130, 50, 40 and 30 kDa. 
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1. INTRODUCTION 
One of the intriguing features of the higher 
eukaryotic aminoacyl-tRNA synthetases i their 
ability to form high-molecular-mass complexes. A
complex containing 8-9 aminoacyl-tRNA syn- 
thetases, specific towards Arg, Asp, Gln, Glu, lie, 
Leu, Met and Pro, has been purified from several 
sources and well characterised [1]. The only 
aminoacyl-tRNA synthetase which was also 
observed in a high-molecular-mass form, but was 
not present in the purified complex is valyl-tRNA 
synthetase [2,3]. This enzyme was supposed to 
form homocomplexes consisting of several sub- 
units of the enzyme [4]. Here, we have succeeded 
in purification of the high-molecular-mass com- 
plex of valyl-tRNA synthetase and show that it is 
composed of several different polypeptides. 
2. EXPERIMENTAL 
We used columns of Sepharose CL-6B, pre- 
packed Mono Q HR 5/5, Mono S HR 5/5 and 
Superose 6 HR 10/30 (Pharmacia), phenyl- 
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methylsulfonyl fluoride (PMSF) (Serva), 
diisopropyl fluorophosphate (DFP) (Merck), ~'- 
mercaptoethanol (Loba Chemie) and [14 C]valine 
(200 Ci/mol). The other reagents were of 
analytical grade. 
The activity of valyl-tRNA synthetase was deter- 
mined as described in [5]. One unit of enzyme ac- 
tivity is defined as the amount required to form 
1 nmol aminoacyl-tRNA per min at 37°C. 
Rabbit liver extract was obtained as in [5] except 
that the concentrations of PMSF and DFP were 
1 raM. 
The extract was further centrifuged at 20000 × g 
for 20 min. The supernatant (50 ml) was im- 
mediately applied onto the Sepharose CL-6B col- 
umn (2.6 x 95 cm), equilibrated with 25 mM 
potassium phosphate buffer (pH 7.5), with 1 mM 
MgClz, I0% glycerol and 2 mM fl-mercapto- 
ethanol (buffer A). Elution was performed at a 
flow rate of 20 ml/h. The size of fractions was 
l0 ml. Active fractions (70 ml) were combined and 
applied on the Mono S column. This and other 
procedures were performed at room temperature. 
Proteins were eluted with a linear gradient of KC1 
from 0 to 0.5 M in buffer A at a flow rate of 
l ml/min. Active fractions were combined, diluted 
twice with buffer A and immediately applied on 
the Mono Q column. Elution was performed with 
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KCI from 0 to 1.0 M in buffer A. Active fractions 
were stored frozen at - 12°C. The specific activity 
of valyl-tRNA synthetase was about 40 U/mg.  
Analytical gel filtration was performed using the 
Superose 6 HR 10/30 column. Protein samples 
(500 #1) were loaded onto the column and eluted at 
a flow rate of 0.5 ml/min in buffer A with 0.3 M 
KC1. 
Electrophoresis was performed according to 
Laemmli [6]. 
Renaturation experiments were carried out as 
described by Waller et al. [7]. 
3. RESULTS AND DISCUSSION 
The purification of valyl-tRNA synthetase in- 
cludes 3 steps - gel filtration of the extract and two 
stages of high-performance ion-exchange chroma- 
tography. Gel filtration of the extract revealed that 
practically all the activity is eluted as a single peak 
corresponding to approx. 800 kDa (fig.l). 
The fractions containing the highest specific ac- 
tivity were used for further purification. During 
chromatography on Mono S (fig.2) some of the 
valyl-tRNA synthetase activity flows through the 
column. This is due to the presence in the fraction 
applied of a considerable amount of RNAs, in- 
cluding tRNA, which are able to elute aminoacyl- 
tRNA synthetase from cation exchangers [8]. Final 
purification was achieved by the use of Mono Q 
chromatography (fig.3). The enzyme is eluted as a 
single peak at extremely high concentration of KC1 
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Fig. 1. Chromatography of the extract on the Sepharose 
CL-6B column. A280 ( ), valyl-tRNA synthetase ac- 
tivity (o-----o). 
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Fig.2. Chromatography of valyl-tRNA synthetase on the 
Mono S HR 5/5 column. A28o ( ), valyl-tRNA syn- 
thetase activity (e, e,). 
- about 0.6 M. The specific activity of the enzyme 
after this step was about 40 U/mg and the 
purification about 1900-fold. 
The fraction thus obtained contains four poly- 
peptides of 130, 50, 40 and 30 kDa, approximately 
in stoichiometric quantities (fig.4). During gel 
filtration all ~ polypeptides and valyl-tRNA syn- 
thetase activity were revealed as a single peak cor- 
responding to 800 kDa with a shoulder at about 
400 kDa (fig.5). Valyl-tRNA synthetase from the 
extract elutes exactly at the same position as the 
purified complex. The minor peak has the same 
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Fig.3. Chromatography of valyl-tRNA synthetase on the 
Mono Q HR 5/5 column. AEso ( ); bars indicate 
valyl-tRNA synthetase activity. 
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Fig.4. SDS electrophoresis of the valyl-tRNA synthetase 
complex after Mono Q chromatography using 10% gel. 
Arrows indicate the positions of molecular mass 
markers: E. coli fl-galactosidase (116 kDa), phosphory- 
lase b (94 kDa), albumin (67 kDa), catalase (60 kDa), 
ovalbumin (43 kDa), lactate dehydrogenase (36 kDa), 
carboanhydrase (30 kDa) and soybean trypsin inhibitor 
(20 kDa). 
polypeptide composition and may result from par- 
tial dissociation of the complex. 
The co-elution of these four polypeptides during 
gel filtration and two different steps of high- 
performance chromatography, and the identity of 
the enzyme's molecular mass in the extract and 
purified preparation lead us to consider that these 
polypeptides exist in the form of a single complex. 
This is supported by the fact that introduction of 
an additional hydroxyapatite stage after, or 
heparin-Sepharose b fore, gel filtration did not 
change the polypeptide composition of the purified 
complex. Heparin-Sepharose chromatography was 
found to destabilise the complex. 
Since the sum of the molecular masses of the 
subunits is 250 kDa, the stoichiometry of the com- 
plex is not clear. It may contain from 2 to 4 sets of 
subunits, if they are present stoichiometrically. 
The single candidate for valyl-tRNA synthetase 
is the 130 kDa polypeptide, since the molecular 
mass of the yeast enzyme is 130 kDa [9] and those 
of yeast and mammalian enzymes are similar [71. 
Fig.5. Gel filtration of the purified valyl-tRNA syn- 
thetase complex on the Superose 6 HR 10/30 column. 
Arrows indicate the elution positions of markers: thyro- 
globulin (699 kDa) and pyruvate kinase (235 kDa). 
This fact is supported by the experiments on re- 
naturation of the enzyme after SDS electro° 
phoresis. 
The function of the other polypeptides remains 
unknown. For example, they may be factors of 
protein biosynthesis, the existence of which in the 
high-molecular-mass form has been reported [2]. 
Work on the stability of the complex and iden- 
tification of the polypeptides i in progress in our 
laboratory. 
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